| Pre-awareness (n = 150) | Post-awareness (n = 150) | p value | |
---|---|---|---|---|
Age in years, mean ± SD | 61.8 ± 12.2 | 65.1 ± 12.7 | 0.024a | |
ASA classification, n (%) | Â | Â | 0.757b | |
 | I/II | 124 (82.7) | 126 (84.0) |  |
 | III/IV | 26 (17.3) | 24 (16.0) |  |
(Suspected) diagnosis, n (%) | Â | Â | 0.110b | |
 | Ovarian cancer | 115 (76.7) | 114 (76.0) |  |
 | Uterine cancer | 27 (18.0) | 34 (22.7) |  |
 | Cervical cancer | 8 (5.3) | 2 (1.3) |  |
Histological subtype, n (%) | Â | Â | 0.111b | |
 | Benign | 37 (24.7) | 27 (18.0) |  |
 | Borderline / hyperplasia | 14 (9.3) | 8 (5.3) |  |
 | Malignant | 99 (66.0) | 115 (76.7) |  |
Surgical approach, n (%) |  |  | >  0.999c | |
 | Midline incision | 147 (98.0) | 147 (98.0) |  |
 | Transverse incision | 3 (2.0) | 3 (2.0) |  |
Operation time in minutes, mean ± SD | 138.9 ± 72.0 | 142.7 ± 67.5 | 0.632a | |
Type of surgery (only ovarian included), n (%) | Â | Â | 0.027b | |
 | Explorative | 50 (43.5) | 40 (35.1) |  |
 | Staging | 13 (11.3) | 6 (5.3) |  |
 | Primary cytoreductive | 11 (9.6) | 25 (21.9) |  |
 | Secondary cytoreductive | 41 (35.7) | 43 (37.7) |  |
Additional surgical procedure, n (%) | Â | Â | Â | |
 | Open-close (inoperable) | 1 (0.7) | 5 (3.3) | 0.214c |
 | Anastomosis | 6 (4.0) | 7 (4.7) | 0.777b |
 | Diverting stoma | 6 (4.0) | 9 (6.0) | 0.427b |
 | Lymphadenectomy | 34 (22.7) | 27 (18.0) | 0.315b |
 | Extensive upper abdominal surgery * | 4 (2.7) | 8 (5.3) | 0.239b |